Oracle's Catz Cashes Out Nearly $1B in Stock Sales Within a Week

Rhea-AI Filing Summary

Oracle Corp Form 144 filing reveals CEO Safra Catz's planned sale of 1,873,791 shares of common stock with an aggregate market value of $397.8 million through Fidelity Brokerage Services. The transaction is scheduled for June 25, 2025, on the NYSE.

Key transaction details:

• Shares were acquired through stock options exercise on June 25, 2025
• Payment was made in cash
• Total outstanding shares: 2.81 billion

Notable recent trading activity by Catz in the past 3 months:

• June 20, 2025: Sold 2,284,371 shares for $474.2 million
• June 23, 2025: Sold 1,410,547 shares for $289.8 million

This Form 144 represents a significant insider transaction, with Catz selling approximately $1.16 billion worth of Oracle stock within a one-week period.

Positive

• None.

Negative

• CEO Safra Catz sold a total of approximately 5.57 million shares worth over $1.16 billion in three transactions within a week, representing a significant insider sale volume

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2025 - 04:12 PM Learn about SEC filing dates

FAQ

How many ORCL shares is Safra Catz planning to sell according to the June 2025 Form 144?

According to the Form 144 filing dated June 28, 2025, Safra Catz plans to sell 1,873,791 shares of Oracle (ORCL) common stock with an aggregate market value of $397,783,719.00 through Fidelity Brokerage Services LLC.

What is the total value of ORCL stock sales by Safra Catz in the past 3 months before the June 2025 Form 144?

In the three months prior to the Form 144 filing, Safra Catz made two significant sales of ORCL stock: 2,284,371 shares on June 20, 2025 ($474,221,028.00) and 1,410,547 shares on June 23, 2025 ($289,786,866.00), totaling approximately $764 million in gross proceeds.

How did Safra Catz acquire the ORCL shares mentioned in the June 2025 Form 144?

According to the filing, Safra Catz acquired the 1,873,791 ORCL shares through a Stock Options Exercise from the Issuer on June 25, 2025, with payment made in cash on the same date.

What percentage of ORCL's outstanding shares does Safra Catz's proposed sale represent?

The proposed sale of 1,873,791 shares represents approximately 0.067% of Oracle's total outstanding shares, which according to the filing stands at 2,808,833,000 shares.

Where and when does Safra Catz plan to execute the ORCL stock sale?

According to the Form 144 filing, Safra Catz plans to execute the stock sale on the NYSE (New York Stock Exchange) with an approximate date of sale of June 25, 2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	1873791	397783719.00	2808833000	06/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2025	Stock Options Exercise	Issuer			1873791	06/25/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SAFRA Catz C/O Oracle corp 2300 ORACLE WAY Austin TX 78741	Common stock	06/20/2025	2284371	474221028.00
SAFRA Catz C/O Oracle corp 2300 ORACLE WAY Austin TX 78741	Common stock	06/23/2025	1410547	289786866.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)